Aspirin-Free Strategies After PCI: Still Not Out of the Twilight

J Am Coll Cardiol. 2019 Oct 22;74(16):2028-2031. doi: 10.1016/j.jacc.2019.08.998.

Authors

Jean-Philippe Collet¹, Gilles Montalescot², Michel Zeitouni²

Affiliations

¹ Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France. Electronic address: jean-philippe.collet@aphp.fr.
² Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.

PMID: 31623759
DOI: 10.1016/j.jacc.2019.08.998

No abstract available

Keywords: drug-eluting stent; dual antiplatelet therapy; multivessel percutaneous coronary intervention; ticagrelor monotherapy.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aspirin
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Ticagrelor

Substances

Platelet Aggregation Inhibitors
Ticagrelor
Aspirin